fda drug shortages semaglutide injection resolved date 2025 Novo's Wegovy and Ozempic removed from US shortage list, compounders on notice ISPOR 2025: Exploring reasons for

While this helps limit side effects, it can make early progress feel slow

Anna Barbieri MD Stay updated Subscribe to our weekly newsletter with cutting edge science, stories & recommendations for the 21st century woman

The most recent Prime Therapeutics study on persistence points to patients increasingly staying on GLP-1s for at least a year

The Receptor Overlap Problem Understanding why combining these compounds is problematic requires examining their receptor profiles

Neuroprotective and anti-apoptotic effects of liraglutide on SH-SY5Y cells exposed to methylglyoxal stress

To view or add a comment, sign in PCSK9 inhibitors and lipoprotein(a): what really happens in real-world practice This large, multi-centre real-world study published in the European Journal of Preventive Cardiology evaluates how PCSK9 inhibitors (PCSK9i) affect lipoprotein(a) [Lp(a)] levels outside randomized trialsand which patients benefit most